Announcements Trials
Browse Landscape

Status

No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 2Rhabdoid Tumor 2Wilms Tumor 1Solid Tumours 1Solid Tumor, Adult 1Solid Tumor Metastatic Cancer Advanced Cancer 1Solid Tumor 1Sarcoma, Synovial 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Retinoblastoma 1Pinealoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Mesothelioma, Malignant 1Meningeal Neoplasms 1Medulloblastoma 1Malignant Solid Tumour 1Hepatoblastoma 1Desmoplastic Small Round Cell Tumor 1Chondrosarcoma 1Carcinoma, Renal Cell 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × Solid Tumor Metastatic Cancer Advanced Cancer × Other solid neoplasm × Clear all
NCT05511350 2022-10-18

Expanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001

I-Mab Biopharma US Limited

No longer available
Other solid neoplasm

Solid Tumor Metastatic Cancer Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡